Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter’s Q3 showed a mixed picture. Revenue from continuing operations rose about 5% year-over-year to $2.84 billion, helped by strong performance in its Pharmaceuticals and Healthcare Systems unitsbaxter.combaxter.com. However, sales fell short of the street’s ~$2.88 billion estimatereuters.com. On profit, Baxter earned an adjusted $0.69 per share, well above the ~$0.60 expectedreuters.comchartmill.com.
30 October 2025
·
Guardant Health (GH) Stock Rockets on Earnings Beat and New Cancer-Screening Wins

Guardant Health (GH) Stock Rockets on Earnings Beat and New Cancer-Screening Wins

Guardant’s latest quarterly report blew past Wall Street’s expectations, sparking a sharp rally in its shares. For Q3 2025, revenue was $265.2 million, a 39% jump from a year ago and well above the ~$235 million analysts had forecastinvesting.com. On an adjusted basis, Guardant lost $0.39 per share, much better than the roughly $0.79 loss expected. Management immediately lifted the full-year sales outlook to $965–970 millioninvestors.guardanthealth.com, up from $915–925M previously. As a result, GH stock jumped nearly 30% in morning trading on Oct. 30seekingalpha.comreuters.com. This breakout comes on top of an already huge run – shares were up over 210% year-over-year before the earnings releaseinvesting.com.
30 October 2025
··
Estée Lauder Stock Soars on Surprise Earnings Beat as Beauty Rebounds – What’s Next?

Estée Lauder Stock Soars on Surprise Earnings Beat as Beauty Rebounds – What’s Next?

Estée Lauder’s stock seesawed on its earnings news. Shares initially surged in pre-market trading on Oct. 30 after the company’s strong quarterly report, jumping about 5% to roughly $102.26ts2.tech. This early spike reflected investor surprise at the better-than-expected results. However, as the trading day wore on, some of those gains evaporated – by midday, EL stock hovered around $97.36, down ~1.4% from the prior closets2.tech. Even with the post-earnings wobble, the stock is still up nearly 30% year-to-datets2.tech, significantly outperforming earlier expectations for the year.
30 October 2025
···
CVU Stock Skyrockets 70% on Missile Contract Win – CPI Aerostructures Surges as Analysts Weigh In

CVU Stock Skyrockets 70% on Missile Contract Win – CPI Aerostructures Surges as Analysts Weigh In

CPI Aerostructures’ stock took off explosively on news of a lucrative missile contract with Raytheon Missiles & Defense. The company announced on October 30 that Raytheon has tapped CPI Aero to manufacture structural missile wing assemblies for an undisclosed missile platformglobenewswire.com. The order is single-source and fixed-price – indicating CPI will be the sole supplier of these components – with production slated to begin in 2026globenewswire.com.
30 October 2025
···
Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Medical Properties Trust’s third-quarter results provided a dose of relief for investors who have endured a turbulent year. Normalized FFO came in at $0.13 per share, comfortably ahead of what many analysts had expectedchartmill.com. This key profit metric for REITs was down from $0.16 a year agobusinesswire.com, reflecting ongoing challenges, but the “beat” versus expectations drew focus. “Investors responded positively to the earnings beat and management’s optimistic commentary,” noted ChartMill, after MPW shares rose about 2–3% in pre-market trading on the reportchartmill.com. Revenue was $237.5 million, roughly flat year-over-year and slightly above Wall Street estimates around $235–240 millionchartmill.com. While essentially stable, this topline performance indicates a possible end to the revenue declines that had worried investors during tenant upheavals, suggesting the core hospital portfolio is stabilizing.
30 October 2025
··
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience’s share price has been on a wild ride in 2025, mostly downhill. The stock now hovers around 40 cents, down from the mid-$2 range a year agofintel.io. In fact, HBIO has lost nearly 84% of its value year-over-yearfintel.io, an astonishing collapse that reflects both company-specific struggles and the broader market rout in small-cap biotech names. Shares cratered to an intraday low of $0.28 in mid-2025 amid intense selling pressureinvesting.com, before staging a modest rebound. Even after some recovery, HBIO remains deep in penny stock territory, a far cry from its 52-week high of $3.27investing.com.
30 October 2025
··
Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power’s stock has been on a wild ride through October. After languishing around $1.50 per share in late summer 2025, PLUG erupted in a hydrogen-fueled rally, reaching a new 52-week high near $4.58 by early Octoberts2.tech. That surge – roughly +170% in a few months – vastly outpaced the broader market. It was amplified by a short squeeze: with roughly one-third of PLUG’s float sold short, each burst of positive news forced bearish traders to buy shares to cover, turbocharging the uptrendts2.tech. Indeed, PLUG logged nearly 100 trading days with swings over 5% in the past yearts2.tech, highlighting extreme volatility.
30 October 2025
······
Intel (INTC) Stock Soars 90% to 18-Month High on AI Boom, $15B Lifeline – Will the Rally Last?

Intel (INTC) Stock Soars 90% to 18-Month High on AI Boom, $15B Lifeline – Will the Rally Last?

Intel shares are in the midst of a dramatic comeback in 2025, riding a wave of optimism that the once-struggling chipmaker can regain its footing in the AI era. Year-to-date, INTC has surged roughly 90%, marking one of the best performances in the semiconductor sector this yearts2.techts2.tech. By late October, the stock was trading around $40–$42 – levels not seen in about two years – after nearly doubling from its January lows of around $20ts2.techtradingnews.com. This torrid rally has significantly outpaced the broader market and even outperformed high-flying rivals Nvidia and AMD in 2025ts2.tech.
30 October 2025
···
Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

São Paulo-based Ambev delivered a stronger-than-expected third quarter, defying the industry’s mixed outlook. Net profit leapt to R$4.86 billion Reuters, a 36% increase from a year ago. This result blew past analysts’ consensus of roughly R$3.2 billion Reuters, reflecting robust operational performance. On a per-share basis, earnings were approximately $0.06 for the quarter – significantly higher than estimates around $0.04.
30 October 2025
··
FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Corporation stunned the market with a far worse-than-expected third quarter, driven by a massive one-time hit in its international operations. The Philadelphia-based crop protection company reported a GAAP net loss of $569.3 million for Q3 2025, a dramatic swing from a $65 million profit in the same quarter last year Benzinga. The red ink stems largely from FMC’s troubled India business, which the firm is preparing to divest. FMC took a $510 million write-down on the India unit’s value and associated assets, writing its carrying value down from about $960 million to $450 million Benzinga. In addition, FMC recorded pre-sale adjustments of roughly $282 million, including product return costs and pricing concessions designed to accelerate collections in India Benzinga. These charges pushed FMC deep into the red and underscore the severity of the issues in that market.
30 October 2025
·
Nvidia’s Record $5 Trillion Surge: AI Mega-Deals Propel NVDA Stock – Is $300 Next?

Nvidia’s Record $5 Trillion Surge: AI Mega-Deals Propel NVDA Stock – Is $300 Next?

Nvidia’s stock has been on a tear in late 2025, repeatedly flirting with all-time highs. Shares closed at about $207 on Oct. 29, a new record that put Nvidia’s market capitalization around $5.03 trillion reuters.com. This milestone makes Nvidia the first company ever to reach a $5 trillion valuation, underscoring how dramatically it has ascended on the back of the AI boom reuters.com. Year to date, NVDA is up roughly 30%, vastly outperforming the S&P 500 index’s gains ts2.tech. The stock has now leaped about 58% from one year ago and stands nearly 12× higher than its level in early 2022 before the AI frenzy began reuters.com. Investor enthusiasm remains intense – even minor dips have been met with eager “buy the dip” flows, reflecting Nvidia’s status as the market’s premier AI play ts2.tech.
30 October 2025
··
Crocs Stock Soars on Surprise Earnings Beat – Can the ‘Ugly Shoe’ Icon Stage a Comeback?

Crocs Stock Soars on Surprise Earnings Beat – Can the ‘Ugly Shoe’ Icon Stage a Comeback?

Crocs stock jumped over 7% on Thursday after the foam-footwear maker reported better-than-expected third-quarter earnings stockstory.org. The company’s Q3 revenue of $996.3 million, though down 6.2% from a year ago, beat analyst estimates by about 3% stockstory.org. Adjusted net income came in at $2.92 per share, trouncing forecasts and indicating Crocs managed to outperform in a tough environment stockstory.org. Management also surprised the market with an upbeat outlook for the holiday quarter: Q4 revenue is projected around $1.07 billion, roughly 15% higher than Wall Street’s expectation, along with solid profit guidance stockstory.org. These strong results and guidance sent CROX shares rallying to around $91 by midday Thursday, as investors cheered the earnings beat and signs of resilience stockstory.org.
30 October 2025
·
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb’s stock has been under pressure for most of 2025, but the Q3 report provided a much-needed boost. Heading into earnings, BMY shares were near 52-week lows, reflecting investor skittishness over looming patent cliffs and mixed news in prior quarters. In fact, on October 28, the stock touched a one-year low of $42.96 Marketbeat. That put BMY down roughly 18–19% year-to-date, significantly underperforming the pharma sector Nasdaq. By comparison, an index of large pharmaceutical stocks was up modestly, making BMY one of 2025’s laggards.
30 October 2025
··
Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria’s third-quarter earnings highlight the tobacco giant’s balancing act between resilient profits and declining cigarette usage. The company reported an adjusted Q3 profit of $1.45 per share, a 3.6% increase year-on-year and exactly in line with analyst expectations reuters.com. However, revenue fell more than anticipated – net revenues came in at $6.07 billion, down ~3% from a year ago reuters.com. This topline drop exceeded Wall Street’s forecasts and underscored weaker cigarette volumes. The mixed results put immediate pressure on MO stock, which fell about 4% ahead of Thursday’s open on the news reuters.com.
30 October 2025
···
Cava Stock Plunges to 52-Week Low – Bargain Buy or More Pain Ahead?

Cava Stock Plunges to 52-Week Low – Bargain Buy or More Pain Ahead?

Cava’s stock has been on a steep slide since its euphoric post-IPO highs. This week, shares tumbled to $54.93, their lowest level in a year za.investing.com. That price is well under half of where CAVA traded 12 months ago za.investing.com, and a far cry from the ~$170 peak the market once ascribed to this high-flying restaurant IPO. In fact, the stock now sits roughly 62% below its peak levels reached after its 2023 IPO ts2.tech. The 52-week high of $172.43 underscores how dramatically sentiment has reversed za.investing.com.
30 October 2025
·
Mario, Donkey Kong, Metroid – Is Nintendo Assembling Its Own “Avengers” Cinematic Universe?

Mario, Donkey Kong, Metroid – Is Nintendo Assembling Its Own “Avengers” Cinematic Universe?

Nintendo is wasting no time extending its intellectual properties to Hollywood after the smash hit of The Super Mario Bros. Movie in 2023. That animated Mario adventure, co-produced with Illumination/Universal, proved that Nintendo’s iconic characters can draw massive crowds beyond the gaming world. It became a global blockbuster with over $1 billion in grosses, prompting Nintendo’s top creatives to double down on film projects Thedirect. In fact, Mario’s success “almost guarantees sequels or other IP adaptations,” as analysts have noted ts2.tech. Nintendo itself hinted in 2024 that it planned to “broaden Mario’s world further” in cinema, and now those plans are taking shape People.
30 October 2025
·
Animal Crossing Comeback: Switch 2 Upgrade & Free Update Pack Mega Surprises for Fans

Animal Crossing Comeback: Switch 2 Upgrade & Free Update Pack Mega Surprises for Fans

Nintendo has officially announced that Animal Crossing: New Horizons is getting a dedicated Switch 2 Edition to take advantage of the next-gen hardware videogameschronicle.com. This upgraded version launches January 15, 2026 alongside the new system’s debut. It isn’t a simple patch – it’s a beefed-up edition with exclusive features for Switch 2 owners. Key enhancements in the Switch 2 Edition include:
30 October 2025
·
Trump-Xi Trade Truce Sends Stocks Tumbling – Markets Brace for Tech Earnings and Fed Moves

Trump-Xi Trade Truce Sends Stocks Tumbling – Markets Brace for Tech Earnings and Fed Moves

At the APEC summit in Busan on Thursday, Trump and Xi touted progress but agreed only to roll back recent trade escalations. Under their framework, Beijing will pause new controls on rare-earth minerals for one year, resume soybean purchases, and work to halt illicit fentanyl exports. In exchange, Trump said U.S. tariffs on Chinese imports will be cut to 47% of their original levels reuters.com. Trump hailed the talks as “amazing” and rated them “12” on a 10-point scale reuters.com, but analysts note the deal stops short of addressing deeper issues reuters.com. As Reuters observes, it amounts to a “fragile truce” rather than a lasting reset reuters.com. Emily Kilcrease of the Center for a New American Security calls it merely “de-escalation of measures that both sides have taken” since the trade war began reuters.com. Bloomberg concurs that the agreements essentially unwind recent punitive steps while promising talks on other fronts bloomberg.com.
30 October 2025
········
Comcast Shocker: Cord-Cutting Slows, Wireless Soars in Q3 Earnings

Comcast Shocker: Cord-Cutting Slows, Wireless Soars in Q3 Earnings

Comcast’s Q3 results trounced Street forecasts. Net income of $3.33 billion translated to $0.90 GAAP EPS, or $1.12 adjusted EPS on $31.2 billion revenue thewrap.com. The revenue marked a 2.7% YoY decline, but topped analyst models. Crucially, last year’s quarter was inflated by the Paris Olympics, so year-on-year comparisons were unfavorable thewrap.com. Even with that Olympic tailwind, Comcast beat estimates, suggesting resilience in its core businesses.
30 October 2025
··
1 … 78 79 80 81 82 … 164

Stock Market Today

  • BOQ Shares: July Valuation and Sector Outlook
    July 26, 2026, 4:27 AM EDT. The Bank of Queensland Limited (ASX: BOQ) last traded at $6.37, posting FY24 earnings per share (EPS) of $0.41 and a resulting price-earnings (PE) ratio of 15.5x, currently lower than the 19x average across the banking sector. When adjusted for sector PE, BOQ's implied value stands around $7.72. Analysts note the Dividend Discount Model (DDM) is appropriate for BOQ given its consistent dividends, a contrast to tech shares. ASX investors continue to watch BOQ as banking sector trends and broader market forces evolve.